MicroRNA-17-92 cluster regulates osteoblast proliferation and differentiation

MicroRNAs (miRNAs) have been identified to play important functions during osteoblast proliferation, differentiation, and apoptosis. The miR-17~92 cluster is highly conserved in all vertebrates. Loss-of-function of the miR-17-92 cluster results in smaller embryos and immediate postnatal death of all animals. Germline hemizygous deletions of MIR17HG are accounted for microcephaly, short stature, and digital abnormalities in a few cases of Feingold syndrome. These reports indicate that miR-17~92 may play important function in skeletal development and mature. To determine the functional roles of miR-17~92 in bone metabolism as well as osteoblast proliferation and differentiation. Murine embryonic stem cells D3 and osteoprogenitor cell line MC3T3-E1 were induced to differentiate into osteoblasts; the expression of miR-17-92 was assayed by quantitative real-time RT-PCR. The skeletal phenotypes were assayed in mice heterozygous for miR-17~92 (miR-17~92+/Δ). To determine the possibly direct function of miR-17~92 in bone cells, osteoblasts from miR-17~92+/Δ mice were investigated by ex vivo cell culture. miR-17, miR-92a, and miR-20a within miR-17-92 cluster were expressed at high level in bone tissue and osteoblasts. The expression of miR-17-92 was down-regulated along with osteoblast differentiation, the lowest level was found in mature osteoblasts. Compared to wildtype controls, miR-17-92+/Δ mice showed significantly lower trabecular and cortical bone mineral density, bone volume and trabecular number at 10 weeks old. mRNA expression of Runx2 and type I collagen was significantly lower in bone from miR-17-92+/Δ mice. Osteoblasts from miR-17-92+/Δ mice showed lower proliferation rate, ALP activity and less calcification. Our research suggests that the miR-17-92 cluster critically regulates bone metabolism, and this regulation is mostly through its function in osteoblasts.

[1]  R Kemler,et al.  The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. , 1985, Journal of embryology and experimental morphology.

[2]  A. Harvey,et al.  Proliferating cells in the primary spongiosa express osteoblastic phenotype in vitro. , 1997, Bone.

[3]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[4]  Hiroyuki Tagawa,et al.  Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. , 2004, Cancer research.

[5]  Chen-Yong Lin,et al.  Inhibition of Tumor Invasion by Genomic Down-regulation of Matriptase through Suppression of Activation of Receptor-bound Pro-urokinase* , 2004, Journal of Biological Chemistry.

[6]  J. Castle,et al.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs , 2005, Nature.

[7]  S. Lowe,et al.  A microRNA polycistron as a potential human oncogene , 2005, Nature.

[8]  Kathryn A. O’Donnell,et al.  c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.

[9]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[10]  P. Jourdon,et al.  Differentiation of osteoblasts from mouse embryonic stem cells without generation of embryoid body , 2007, In Vitro Cellular & Developmental Biology - Animal.

[11]  J. M. Thomson,et al.  Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. , 2007, Developmental biology.

[12]  C. Long,et al.  Identification, amplification and characterization of miR-17-92 from canine tissue. , 2007, Gene.

[13]  P. Jourdon,et al.  Concise Review: Embryonic Stem Cells: A New Tool to Study Osteoblast and Osteoclast Differentiation , 2007, Stem cells.

[14]  C. Croce,et al.  Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. , 2008, Cancer research.

[15]  Avner Friedman,et al.  MicroRNA regulation of a cancer network: Consequences of the feedback loops involving miR-17-92, E2F, and Myc , 2008, Proceedings of the National Academy of Sciences.

[16]  A. Palmieri,et al.  Medpor regulates osteoblast's microRNAs. , 2008, Bio-medical materials and engineering.

[17]  G. Stein,et al.  A microRNA signature for a BMP2-induced osteoblast lineage commitment program , 2008, Proceedings of the National Academy of Sciences.

[18]  Rudolf Jaenisch,et al.  Targeted Deletion Reveals Essential and Overlapping Functions of the miR-17∼92 Family of miRNA Clusters , 2008, Cell.

[19]  Y. Okazaki,et al.  miR‐210 promotes osteoblastic differentiation through inhibition of AcvR1b , 2009, FEBS letters.

[20]  Hiroyuki Tagawa,et al.  MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes. , 2008, Blood.

[21]  Carlo M. Croce,et al.  Biological Functions of miR-29b Contribute to Positive Regulation of Osteoblast Differentiation* , 2009, The Journal of Biological Chemistry.

[22]  Joong-Su Kim,et al.  The Major Outer Membrane Protein of a Periodontopathogen Induces IFN-β and IFN-Stimulated Genes in Monocytes via Lipid Raft and TANK-Binding Kinase 1/IFN Regulatory Factor-31 , 2009, The Journal of Immunology.

[23]  Xijie Yu,et al.  Loss-of-function of SHARPIN causes an osteopenic phenotype in mice , 2010, Endocrine.

[24]  Di Chen,et al.  MicroRNA‐204 Regulates Runx2 Protein Expression and Mesenchymal Progenitor Cell Differentiation , 2009, Stem cells.

[25]  Jie Xiang,et al.  Feud or Friend? The Role of the miR-17-92 Cluster in Tumorigenesis , 2010, Current genomics.

[26]  C. Kuo,et al.  miR-17-92 angiogenesis micromanagement. , 2010, Blood.

[27]  L. Tang,et al.  MiR‐17 Modulates Osteogenic Differentiation Through a Coherent Feed‐Forward Loop in Mesenchymal Stem Cells Isolated from Periodontal Ligaments of Patients with Periodontitis , 2011, Stem cells.

[28]  Xiang-hang Luo,et al.  A Runx2/miR-3960/miR-2861 Regulatory Feedback Loop during Mouse Osteoblast Differentiation* , 2011, The Journal of Biological Chemistry.

[29]  G. Stein,et al.  A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2 , 2011, Proceedings of the National Academy of Sciences.

[30]  Patrick Callier,et al.  Germline deletion of the miR-17-92 cluster causes growth and skeletal defects in humans , 2011, Nature Genetics.

[31]  G. Stein,et al.  Effects of miR‐335‐5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1 , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[32]  Patrick Callier,et al.  Germline deletion of the miR-1792 cluster causes growth and skeletal defects in humans , 2011 .

[33]  F. Rivadeneira.  Hunting osteoporosis susceptibility genes: bigger is better but diverse is also welcome , 2013, Endocrine.

[34]  Lin Zhao,et al.  The influence of the genetic and non-genetic factors on bone mineral density and osteoporotic fractures in Chinese women , 2013, Endocrine.

[35]  M. Andersen,et al.  Genetic association study of WNT10B polymorphisms with BMD and adiposity parameters in Danish and Belgian males , 2013, Endocrine.

[36]  L. Deng,et al.  MicroRNA-17-92a upregulation by estrogen leads to Bim targeting and inhibition of osteoblast apoptosis , 2013, Journal of Cell Science.